Sesen Bio Announces Proposed Public Offering of Common Stock and Warrants Yahoo Finance
Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today …
Sesen Bio Announces Proposed Public Offering of Common Stock and Warrants Yahoo Finance
Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today …